Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas Aeruginosa

NCT01577368 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Pseudomonas Aeruginosa Infection

Interventions

DRUG: Piperacillin-Tazobactam continuous infusion
DRUG: Piperacillin-Tazobactam intermittent infusion

Sponsor

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]